Argentina vs Italy: HIV/AIDS deaths averted by antiretroviral therapy
Argentina
4,021 deaths
in 2024
Italy
4,048 deaths
in 2024
Argentina rank
46th
Italy rank
45th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Argentina
- Italy
How they compare
Italy currently reports 4,048 deaths against 4,021 deaths in Argentina, a difference of 27 deaths.
Across all 35 years both countries report, Italy has been ahead every year.
Argentina ranks 46th and Italy ranks 45th of 157 countries.
Italy has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Argentina | Italy | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 149.65 deaths | 710.23 deaths | 560.58 deaths | Italy |
| 2000s | 2,595 deaths | 4,451 deaths | 1,857 deaths | Italy |
| 2010s | 3,781 deaths | 4,398 deaths | 617.6 deaths | Italy |
| 2020s | 4,018 deaths | 4,155 deaths | 136.77 deaths | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Argentina or Italy?
- Italy, at 4,048 deaths against 4,021 deaths in Argentina as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Argentina and Italy?
- 27 deaths, with Italy ahead.
- How many years of comparable data are there for Argentina and Italy?
- 35 years are reported by both, from 1990 to 2024.
- How do Argentina and Italy rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Argentina ranks 46th and Italy ranks 45th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.